Wednesday, February 06, 2008

Ignoring not the solution

Just came across an interesting article by D Ravi Kanth ‘Drug Capitalism’ pointing out the concern for affordable drugs to poor consumers, but what really caught my attention is, what Kanth pointed to be moot issue, whether the gap between those who invest billions of dollars to develop new medicines and those who need them most, particularly, the poorest of the poor, is bridgeable.

Undeniably, this is the core issue that need utmost attention across the globe including India, but unfortunately the issue is made diluted by raging politics over ‘Patients or Patents’.

No comments:

Post a Comment